Because it’s a paid service, I’m starting to believe ol’ Jack is fielding the questions for Nadar. I mean, can anyone be that daft? That question about deaths due to Leronlimab in the trials!!#%!!! I really wanted to know if the co. got capitalized with the recent warrant conversions or if they were able to sell (last time I checked 10-12mm) shares during the run-up.
How many of the 6 weeks to uplisting have passed anyways? I’ve lost track.